(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTAGONISTAS DO RECEPTOR MUSCARÍNICO M3 DE ACETILCOLINA

ArquivadaInvention PatentPCT · US2004040668

Application data

Number

PI0417343

Type

Invention Patent

Filing

12/03/2004

Publication

03/13/2007

PCT

US2004040668

Progress at the INPI

  1. Filing12/03/04
  2. Publication03/13/07
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/03/2004 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/21/2009. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Glaxo Group Limited

GB

See this company's full portfolio

Inventors

F. W. (pessoa física)

US

J. B. (pessoa física)

US

J. J. (pessoa física)

US

M. P. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

60/526.766 · 12/03/2003

Abstract

"ANTAGONISTAS DO RECEPTOR MUSCARÍNICO M~ 3~ DE ACETILCOLINA". São providenciados antagonistas do receptor muscarínico de acetilcolina e métodos de uso dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

07/21/2009

RPI 2011

Arquivamento - Art. 33 da LPI

#11.1

04/28/2009

RPI 1999

Notificação de entrada na fase nacional - PCT

#1.3

03/13/2007

RPI 1888

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.